Biolinerx Ltd ADR (BLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 8,856 | 8,398 | 7,078 | 7,602 | 6,079 |
| Operating Income | -8,856 | -8,398 | -7,078 | -7,602 | -6,079 |
| Interest Expense | 927 | 1,326 | 267 | 379 | 186 |
| Other Income | -2,379 | 3,993 | 498 | 538 | 1,335 |
| Pre-tax Income | -12,162 | -5,731 | -6,847 | -7,443 | -4,930 |
| Net Income Continuous | -12,162 | -5,731 | -6,847 | -7,443 | -4,930 |
| Net Income | $-12,162 | $-5,731 | $-6,847 | $-7,443 | $-4,930 |
| EPS Basic Total Ops | -6.00 | N/A | -6.00 | -6.00 | -6.00 |
| EPS Basic Continuous Ops | -7.91 | -3.42 | -5.55 | -6.24 | -4.14 |
| EPS Diluted Total Ops | -6.00 | N/A | -6.00 | -6.00 | -6.00 |
| EPS Diluted Continuous Ops | -7.91 | -3.42 | -5.55 | -6.24 | -4.14 |
| EBITDA(a) | $-8,597 | $-8,211 | $-6,925 | $-7,461 | $-5,906 |